OCT 03, 2017 03:18 PM PDT
Parkinson's Drug Activates a Cancer-Fighting Protein
WRITTEN BY: Xuan Pham
3 8 508

Image credit: Pixabay.com

A drug commonly used to treat symptoms of Parkinson’s disease may have the capacity to stop pancreatic tumor cells from growing, reports a new study.

The current study stems from previous observations showing Parkinson’s patients seem to have a reduced incidence of cancer. Could this be because of the drugs that Parkinson’s patients take?

Common drugs prescribed to help Parkinson’s patients include carbidopa in conjunction with levodopa (L-Dopa). However, previous studies that looked into whether L-Dopa conferred anti-cancer effects did not find promising evidence.

This time, researchers from the Texas Tech University Health Sciences Center (TTUHSC) focused on carbidopa, hoping this is the drug behind the anti-cancer effects.

"Interestingly, no one has previously suspected carbidopa as a potential player in this phenomenon,” said Dr. Yangzom Bhutia, the study’s senior research author. "Carbidopa is never used by itself as a drug for any disease. But [...] we believe that the reduced incidence of most cancers in Parkinson's disease patients is due to carbidopa."

The team exposed carbidopa to human pancreatic cell lines, chosen specifically because of pancreatic cancer’s notorious reputation as one of the most ruthless killers. "Pancreatic cancer, especially the pancreatic ductal adenocarcinoma, is the most lethal of all cancers with a dismal survival rate,” said Dr. Bhutia.

With carbidopa treatment, the tumor cells were less able to form colonies, suggesting carbidopa slowed the cells’ ability to grow.

When the team tested carbidopa in a mouse model of pancreatic cancer, they observed similar promising results. Mice treated with carbidopa had smaller tumors, by volume and weight, as compared to the untreated mice.

The team also observed that carbidopa activated a protein, known as aryl hydrocarbon receptor (AhR), has been shown to have anti-cancer effects. In addition to the pancreatic cancer cell lines, activation of the AhR protein was seen in liver cancer cell lines. "Hence carbidopa could potentially be repurposed to treat pancreatic cancer and possibly other cancers as well,” the authors speculated.

"Carbidopa as an anti-cancer agent to treat pancreatic cancer would be something truly amazing. Given the fact that it is an FDA-approved drug, repurposing the same drug for cancer treatment would be tremendously cost- and time-saving,” Dr. Bhutia said. "Our laboratory is actively working to determine if there are additional targets for this drug related to its potency as an anti-cancer drug."

Of note, the most common type of pancreatic cancer is known as pancreatic ductal adenocarcinoma (PDAC). It accounts for a small percentage of all diagnosed cancer (around 3 percent), but claims an aggressive number of lives (around 7 percent of all cancer-related deaths in the US). It’s estimated that of the 53,000 Americans who will be diagnosed with pancreatic cancer this year, almost 79 percent will succumb from the disease.

Additional sources: MNT

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 10, 2018
Cancer
APR 10, 2018
Gastric Cancer Screening Tool Using Serum Biomarkers Being Studied in South Korea
A group in South Korea are conducting a clinical trial to evaluate a diagnostic screening tool for gastric cancer using serum biomarkers and the ideal interval for screening endoscopies.
MAY 01, 2018
Cancer
MAY 01, 2018
CNS Tumor Cells Destroyed by Zika Virus
CNS tumor classification changed in 2016 to incorporate tumor molecular markers. Researchers look at CNS tumor cells and destroy them with Zika virus infection
MAY 23, 2018
Cell & Molecular Biology
MAY 23, 2018
Understanding Eye Lens Development
As the lens forms during development, its cells have to degrade some of their own parts.
JUN 05, 2018
Cell & Molecular Biology
JUN 05, 2018
Mechanism of Aspirin's Anti-Colon Cancer Effects Revealed
For some people, aspirin can help prevent colon cancer; now researchers have learned more about how that happens.
JUN 05, 2018
Cancer
JUN 05, 2018
Precision vs. Personalized Medicine Part II: Personalized Approach
So often the phrases "Precision Medicine" and "Personalized Medicine" are used interchangeably. Are they really synonyms? Part II looks at Personalized Medicine
JUL 04, 2018
Drug Discovery
JUL 04, 2018
Identifying New Drug Targets in Therapy-Resistant Cancers
Recent research published in the Nature Partner journal Systems Biology and Applications examines how genome-wide data used in collaboration with systems b
Loading Comments...